Active	Status	Sponsor type	Region	Phase	Filter
12 Active 2 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wei, Dong
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus	Not yet recruiting	2	318	RoW	HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	Type 2 Diabetes	04/25	04/25
Wang, Guofeng
NCT05849727: A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis	Recruiting	2	180	RoW	TQH3821 tablets 200 mg, TQH3821 tablets matching placebo	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Rheumatoid Arthritis	06/24	12/24